肥胖与机械通气危重儿童的镇静剂剂量、镇静反应及临床结局的关系
本文为RESTORE儿科多中心临床试验的二次分析,纳入美国31个PICU中1-17岁机械通气患儿,按世界卫生组织与美国疾病控制与预防中心标准分为肥胖与非肥胖组。肥胖发生率为22%。肥胖不影响阿片类药物选择,但延长了阿片类暴露时间;按入院体重计算的每公斤剂量无差异,导致肥胖患儿每日及累积剂量显著更高。在方案化镇静组中,肥胖患儿的中位阿片类剂量显著高于非肥胖方案化镇静组,且镇静不足次数更多、达到拔管准备时间更长、机械通气及PICU住院时间更长、28天院内死亡率更高;这些基于体重的差异在常规护理组中未观察到。作者认为,在为急性呼吸衰竭儿童选择和阿片类药物 dosing 时应考虑体型,肥胖对药物暴露和临床结局有实质影响,尤其在结构化方案化镇静方案中。
要点
- 肥胖发生于22%的机械通气危重患儿,肥胖不影响阿片类药物选择,但延长了阿片类药物暴露时间。
- 按入院体重计算的每公斤剂量在肥胖与非肥胖患儿间无差异,导致肥胖患儿每日及累积阿片类剂量显著更高。
- 方案化镇静组中,肥胖患儿中位阿片类剂量显著高于非肥胖方案化镇静组,且镇静不足次数更多。
- 方案化镇静组中,肥胖患儿达到拔管准备时间更长、机械通气及PICU住院时间更长、28天院内死亡率更高。
- 上述基于体重的差异在常规护理组中未观察到。
适用人群与场景
- 美国31个PICU中1-17岁机械通气患儿,按世界卫生组织与美国疾病控制与预防中心标准分为肥胖与非肥胖组。
诊断标准与关键阈值
- 肥胖判定采用世界卫生组织与美国疾病控制与预防中心标准。
研究设计与关键结果
- 研究类型为RESTORE儿科多中心临床试验的二次分析,纳入美国31个PICU中1-17岁机械通气患儿。
- 肥胖发生率为22%;肥胖不影响阿片类药物选择,但延长了阿片类药物暴露时间。
- 按入院体重计算的每公斤剂量在肥胖与非肥胖组间无差异,导致肥胖患儿每日及累积剂量显著更高。
- 方案化镇静组中,肥胖患儿中位阿片类剂量显著高于非肥胖方案化镇静组。
- 方案化镇静组中,肥胖患儿与非肥胖患儿相比,镇静不足次数更多、达到拔管准备时间更长、机械通气时间及PICU住院时间更长、28天院内死亡率更高。
- 上述基于体重的差异在常规护理组中未观察到。
证据类型、等级与局限
- 证据类型:RESTORE儿科多中心临床试验的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在为急性呼吸衰竭儿童选择和阿片类药物 dosing 时应考虑体型。
- 作者认为,肥胖对药物暴露和临床结局有实质影响,尤其在结构化方案化镇静方案中。
- 作者指出,需要进一步研究探讨肥胖儿童中药物剂量与临床结局之间的复杂关系。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to investigate the impact of obesity on the use of analgesics and sedatives, rates of iatrogenic withdrawal syndrome (IWS), and outcomes in mechanically ventilated pediatric patients. Additionally, it sought to assess whether a nurse-implemented sedation protocol would be equally effective for children with and without obesity.
DESIGN: Secondary analysis of the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) pediatric multicenter clinical trial.
SETTING: Thirty-one U.S. PICUs.
PATIENTS: Children 1-17 years old, categorized as with or without obesity according to World Health Organization and Centers for Disease Control and Prevention criteria.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The study assessed various factors including medication exposure, adequacy of pain and sedation management, IWS rates, and clinical outcomes. Obesity occurred in 22% of patients. Obesity did not influence choice of opiate, but it led to extended exposure to these medications. There were no differences in dosing per kilogram of admission weight, resulting in significantly higher daily and cumulative doses in those with obesity. In the protocolized sedation arm, patients with obesity received significantly higher median opiate doses compared with the nonobesity protocolized sedation group. IWS rates did not differ; however, protocolized sedation obesity patients experienced more instances of inadequate sedation, longer time to extubation readiness, longer duration of mechanical ventilation and PICU stay, and higher 28-day in-hospital mortality than the protocolized sedation nonobesity group. These weight-based differences were not noted in the usual care arm.
CONCLUSIONS: This study underscores the significance of accounting for body habitus when selecting and dosing opiates in children with acute respiratory failure. Obesity had substantial impact on medication exposure and clinical outcomes, particularly within a structured, protocolized sedation regimen. Further research is warranted to explore the intricate relationship between medication dosing and clinical outcomes in children with obesity.
参考来源
- Ward SL, Dawkins-Henry OS, Asaro LA, et al. Association of Obesity With Sedative Dosing, Sedative Response, and Clinical Outcomes in Mechanically Ventilated Critically Ill Children. Crit Care Explor. 2025. PMID: 39932727. doi:10.1097/CCE.0000000000001214
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。